The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 18, 2020

Filed:

Nov. 08, 2016
Applicant:

Ngm Biopharmaceuticals, Inc., South San Francisco, CA (US);

Inventors:

Lei Ling, Foster City, CA (US);

Jian Luo, Albany, CA (US);

Hui Tian, Foster City, CA (US);

Assignee:

NGM Biopharmaceuticals, Inc., South San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); C07K 14/50 (2006.01); A61P 1/16 (2006.01); A61K 9/00 (2006.01); A61K 31/575 (2006.01);
U.S. Cl.
CPC ...
A61K 38/1825 (2013.01); A61P 1/16 (2018.01); C07K 14/50 (2013.01); A61K 9/0019 (2013.01); A61K 31/575 (2013.01);
Abstract

Provided herein are variants of fibroblast growth factor 19 (FGF19) proteins and peptide sequences (and peptidomimetics) and fusions of FGF19 and/or fibroblast growth factor 21 (FGF21) proteins and peptide sequences (and peptidomimetics), and variants of fusions of FG-F19 and/or FGF21 proteins and peptide sequences (and peptidomimetics). In some embodiments, these variants and fusions modulate bile acid homeostasis, and are useful in treatment of bile acid related and associated disorders. In some embodiments, these variants and fusions have glucose lowering activity, and are useful in treatment of hyperglycemia and other disorders.


Find Patent Forward Citations

Loading…